S 9795

Known as: S-9795 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-1989
01219871989

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The xanthine derivative 1-methyl 3-isobutyl 8-(2-ethyl[1-(4-diphenylmethyl piperazinyl)])3, 7-dihydro (1H) purine 2, 6-dione (S… (More)
Is this relevant?
1990
1990
S 9795 (1-methyl-3-isobutyl-8-[2-ethyl 1-(4-diphenylmethylpiperazinyl)]- 3,7-dihydro(1H)purine-2,6-dione) is a new xanthine… (More)
Is this relevant?
1989
1989
In the literature, it remains uncertain whether methylxanthines inhibit hypoxic pulmonary vasoconstriction. We examined the… (More)
  • table 1
  • table 2
  • table 4
  • figure 3
  • figure 2
Is this relevant?
1989
1989
The relationships between plasma and brain concentrations of S 9795 and its main metabolites after single intravenous doses of S… (More)
  • figure I
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1988
1988
We investigated the effects of progressively increased i.v. doses of theophylline and of the newly introduced methylxanthine… (More)
Is this relevant?
1987
1987
The bronchodilating effect and other related pharmacological properties of an 8-amino alkyl substituted xanthine (S 9795) were… (More)
Is this relevant?